Effect of follow-up time on the ability of subcutaneous epcoritamab to induce deep and durable complete remissions in patients with relapsed/refractory large B-cell lymphoma: Updated results from the pivotal EPCORE NHL-1 trial.

Authors :: Karimi, Yasmin
Ghesquieres, Herve
Jurczak, Wojciech
Cheah, Chan
Clausen, Michael
Lugtenburg, Pieternella
Cunningham, David
Do, Young Rok
Lewis, David John
Gasiorowski, Robin
Kim, Tae Min
van der Poel, Marjolein
Poon, Michelle Li Mei
Feldman, Tatyana A
Linton, Kim M.
Sureda, Anna
Hutchings, Martin
Cota Stirner, Mariana
Sacchi, Mariana
Thieblemont, Catherine
Source :: Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, p7525-7525, 1p
Publication Year :: 2023

Full Text Access

Tools